Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL20917840 | 0.91 | HSD11B1 (0.40) | HSD11B1 | |
| SCHEMBL10588633 | 0.81 | HSD11B1 (0.30) | HSD11B1 | |
| SCHEMBL3061024 | 0.79 | — | — | |
| SCHEMBL4443715 | 0.77 | HSD11B1 (0.31) | HSD11B1 | |
| SCHEMBL7531545 | 0.76 | — | — | |
| SCHEMBL3360556 | 0.73 | — | — | |
| SCHEMBL8758690 | 0.72 | — | — | |
| SCHEMBL10642631 | 0.72 | — | — | |
| SCHEMBL8759132 | 0.72 | — | — | |
| SCHEMBL789243 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117448306-A | Creatine amidinohydrolase mutant applied to creatinine detection and mutation site selection, purification and detection method thereof | 上海天鹜科技有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-112763609-B | Research method for screening and extracting process of anti-asthma active ingredients of chamomile | 新疆医科大学第四附属医院 | 2022-08-26 | — | — | CN | claimed |
| CN-103076325-B | Quality control method for blood sugar-lowering preparation | XIAMEN GOLDEN SUN PHARMACEUTICAL CO LTD | 2015-04-22 | — | — | CN | claimed |
| CN-103076325-A | Quality control method for blood sugar-lowering preparation | XIAMEN GOLDEN SUN PHARMACEUTICAL CO LTD | 2013-05-01 | — | — | CN | claimed |
| US-4814427-A | BONDING STRENGTH | THREE BOND COMPANY, LTD. (JP) | 1989-03-21 | — | — | US | claimed |
| EP-0271675-A2 | Primer for alpha-cyanoacrylate-base resin compositions | THREE BOND CO., LTD. (JP) | 1988-06-22 | — | — | EP | claimed |
| CN-120009213-A | Method for measuring urea content in compound urea emulsifiable paste | 武汉市皮肤病防治院 | 2025-05-16 | — | — | CN | disclosed |
| US-12296037-B2 | Fusion proteins for hydroxylating amino acids and products | HTL BIOTECHNOLOGY INNOVATION, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| US-12275763-B2 | RamA transcription factor mutant for promoting production of N-acetylglucosamine and use thereof | JIANGNAN UNIVERSITY (CN) | 2025-04-15 | — | — | US | disclosed |
| CN-119679829-A | Preparation method and application of American cockroach ground powder | 大理大学 | 2025-03-25 | — | — | CN | disclosed |
| US-20250092020-A1 | IDO/TDO Inhibitor | GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION (JP) | 2025-03-20 | — | — | US | disclosed |
| US-12209079-B2 | IDO/TDO inhibitor | GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION (JP) | 2025-01-28 | — | — | US | disclosed |
| CN-119376184-A | Composition comprising a surface treatment component or a cure promoting component | 三键有限公司 | 2025-01-28 | — | — | CN | disclosed |
| EP-0462020-A2 | Anti-herpes agents and veterinary anti-herpes agent | CHIBA FLOUR MILLING CO. LTD. (JP) | 1991-12-18 | — | — | EP | disclosed |
| EP-0397097-A1 | Cultivation of transformed microorganisms | RESEARCH ASSOCIATION FOR UTILIZATION OF LIGHT OIL (JP) | 1990-11-14 | — | — | EP | disclosed |
| EP-0384798-A1 | Limulus test-positive plant glycolipid, and method of stimulating the immuno system of an animal | Soma, Gen-Ichiro (JP) | 1990-08-29 | — | — | EP | disclosed |
| US-4814427-A | BONDING STRENGTH | THREE BOND COMPANY, LTD. (JP) | 1989-03-21 | — | — | US | disclosed |
| EP-0271675-A2 | Primer for alpha-cyanoacrylate-base resin compositions | THREE BOND CO., LTD. (JP) | 1988-06-22 | — | — | EP | disclosed |
| US-4021403-A | EPOXY RESINS, HALOGENATED POLYHYDROXY STYRENE | MARUZEN OIL CO. LTD. (JA) | 1977-05-03 | — | — | US | disclosed |
| US-4020225-A | THERMOSETTING RESIN COMPRISING AN EPOXY RESIN AND A HALOGENATED POLYHYDROXYSTYRENE | MARUZEN OIL CO. LTD. (JA) | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12209079-B2 | IDO/TDO inhibitor | IDO1, IDO2, TDO2 | HSD11B1 200/4885 |
| US-20250092020-A1 | IDO/TDO Inhibitor | IDO1, IDO2, TDO2 | HSD11B1 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.